2,166 results on '"Richards, A. Mark"'
Search Results
2. Global longitudinal strain and plasma biomarkers for prognosis in heart failure complicated by diabetes: a prospective observational study
3. Multiple circulating forms of neprilysin detected with novel epitope-directed monoclonal antibodies
4. Remote intensive management to improve antiplatelet adherence in acute myocardial infarction: a secondary analysis of the randomized controlled IMMACULATE trial
5. The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions
6. Personalized diagnosis in suspected myocardial infarction
7. Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness
8. Mandibular Advancement vs CPAP for Blood Pressure Reduction in Patients With Obstructive Sleep Apnea
9. Haemodynamic changes in visceral hybrid repairs of type III and type V thoracoabdominal aortic aneurysms
10. Cardiac effects of myoregulin in ischemia-reperfusion
11. Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure
12. Machine Learning for Myocardial Infarction Compared With Guideline-Recommended Diagnostic Pathways
13. Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction
14. Combined Inhibition of Phosphodiesterase-5 and -9 in Experimental Heart Failure
15. Clinical use of beta-blocker therapy in patients with heart failure : a practical guide
16. Clinical Features of Heart Failure With Normal Ejection Fraction: Insights From the ASIAN-HF Registry
17. Injectable liposomal docosahexaenoic acid alleviates atherosclerosis progression and enhances plaque stability
18. Association Between Diabetes, Chronic Kidney Disease, and Outcomes in People With Heart Failure From Asia
19. Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF
20. Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure
21. Transcatheter targeted myocardial restoration using hydrogel-based cell-free compound: Toward an adoptable clinical protocol
22. Augmentation of Natriuretic Peptide Bioactivity via Combined Inhibition of Neprilysin and Phosphodiesterase-9 in Heart Failure
23. Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study
24. Determination of Clinically Acceptable Analytical Variation of Cardiac Troponin at Decision Thresholds
25. Morphological, functional, and biomechanical progression of LV remodelling in a porcine model of HFpEF
26. One-Shot Generation of Epitope-Directed Monoclonal Antibodies to Multiple Nonoverlapping Targets: Peptide Selection, Antigen Preparation, and Epitope Mapping
27. Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study
28. Finding a reliable assay for soluble neprilysin
29. Endothelial Damage Arising From High Salt Hypertension Is Elucidated by Vascular Bed Systematic Profiling
30. Loss of full-length pumilio 1 abrogates miRNA-221-induced gene p27 silencing-mediated cell proliferation in the heart
31. Cardiac mesh morphing method for finite element modeling of heart failure with preserved ejection fraction
32. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction
33. Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction.
34. Prognostic Significance and Biologic Associations of Senescence-Associated Secretory Phenotype Biomarkers in Heart Failure.
35. Haemodynamic, hormonal and renal actions of osteocrin in normal sheep.
36. Plasma soluble fms‐like tyrosine kinase‐1, placental growth factor, and vascular endothelial growth factor system gene variants as predictors of survival in heart failure.
37. Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study
38. Prevalence and Prognostic Significance of Frailty in Asian Patients With Heart Failure: Insights From ASIAN-HF
39. Proteomic Associations of Adverse Outcomes in Human Heart Failure
40. ‘Micro’‐managing heart failure: Restoring that which was lost in translation
41. Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approach
42. NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories
43. Outcomes of a multi-ethnic Asian population on combined treatment with clopidogrel and omeprazole in 12,440 patients
44. Emerging microRNA biomarkers for acute kidney injury in acute decompensated heart failure
45. Aging-induced isoDGR-modified fibronectin activates monocytic and endothelial cells to promote atherosclerosis
46. What we know about cardiomyocyte dedifferentiation
47. microRNA-221 Inhibits Latent TGF-β1 Activation through Targeting Thrombospondin-1 to Attenuate Kidney Failure-Induced Cardiac Fibrosis
48. Longitudinal NT-proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure.
49. Derivation and Validation of Thresholds Using Synthetic Data Methods for Single-Test Screening of Emergency Department Patients with Possible Acute Myocardial Infarction Using a Point-of-Care Troponin Assay.
50. Early kinetic profiles of troponin I and T measured by high-sensitivity assays in patients with myocardial infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.